MMJ Group Holdings (ASX:MMJ) says MediPharm Labs is already replenishing and increasing inventory to ensure uninterrupted cannabis oil supply for its existing customers for Q1 2019.
They purchased over 1,600 kg of additional dried cannabis from 7 different licensed producers between December 18, 2018 and January 8, 2019,
They hope to satisfy the robust and growing market demand for high quality purified concentrates.
MMJ owns approximately 4.4 million shares for a 4.3 per cent shareholding and 2.9 million warrants in MediPharm Labs.
Shares in MMJ Group Holdings (ASX:MMJ) are trading flat at $0.24.